Coons JC, Barcelona RA et al. Eptifibatide-associated acute, profound thrombocytopenia. Ann Pharmacother. Feb 2005;39(2):368-72.
Dalby M, Montalescot G et al. Eptifibatide provides additional platelet inhibition in non-ST-elevation myocardial infarction patients already treated with aspirin and clopidogrel. Results of the platelet activity extinction in non-Q-wave myocardial infarction with aspirin, clopidogrel, and eptifibatide (PEACE) study. J Am Coll Cardiol.Jan 2004;43(2):162-8.
Gurbel PA, Bliden KP et al. Clopidogrel loading with eptifibatide to arrest the reactivity of platelets: results of the Clopidogrel Loading With Eptifibatide to Arrest the Reactivity of Platelets (CLEAR PLATELETS) study. Circulation. Mar 2005;111(9):1153-9.
Full Name
Eptifibatide
Alias
Integrilin
Sequence (three-letter code)
MPA-ARG-GLY-ASP-TRP-PRO-CYS-NH2
C-Terminal
NH2
Chemical Bridge
Mpa1-Cys7
Description
Eptifibatide is a cyclic heptapeptide containing six amino acids and one mercaptopropionyl (des-amino cysteinyl) residue. An interchain disulfide bridge is formed between the cysteine amide and the mercaptopropionyl moieties. Chemically it is N6 -(aminoiminomethyl)-N2 -(3-mercapto-1-oxopropyl-L- lysylglycyl-L-a-aspartyl- L-tryptophyl-L -prolyl-L-cysteinamide, cyclic (1Ø6)-disulfide. Eptifibatide binds to the platelet receptor glycoprotein (GP) IIb/IIIa of human platelets and inhibits platelet aggregation.
Formula
C35H19N11O9S2
M.W.
831.96
Cas
188627-80-7
Purity
> 95%
Storage
Store at -20°C. Keep tightly closed. Store in a cool dry place.
* For Non-Clinical Research Use Only *
Our customer service is available 24 hours a day, Monday through Friday. You may contact us any time for assistance.
